NCT06351631 2026-02-20
MK-3543-017
Merck Sharp & Dohme LLC
Phase 3 Recruiting
Clinical Trials
5 trialsNCT06093672 2026-01-27
GIV-IN-PV
Italfarmaco
Phase 3 Recruiting
NCT05481151 2025-08-13
A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV
PharmaEssentia
Phase 3 Active not recruiting
NCT05210790 2025-08-07
VERIFY
Protagonist Therapeutics, Inc.
Phase 3 Active not recruiting
NCT06033586 2025-08-06
THRIVE
Protagonist Therapeutics, Inc.
Phase 3 Active not recruiting